Current Value
$2.241 Year Return
Current Value
$2.241 Year Return
SeekingAlpha
Stay ahead of the market with Seeking Alpha's Wall Street Week Ahead newsletter.
SeekingAlpha
Stay ahead of the market with Seeking Alpha's Wall Street Week Ahead newsletter.
Yahoo
Roth MKM lowered the firm’s price target on CervoMed (CRVO) to $4 from $45 and keeps a Buy rating on the shares. The company has reported negative top-line results from the Phase 2b RewinD-LB – dementia with Lewy bodies – study of neflamapimod in pure DLB patients, raising questions about the program’s viability, the analyst tells investors in a research note. A potential reason for failure could be the drug’s inability to achieve the desired plasma concentration – a proxy for efficacy – and Cer
Yahoo
BOSTON, Dec. 12, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO) (the “Company”), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that it has granted equity awards as a material inducement to the employment of two new employees. On December 6, 2024, the Company granted options to purchase an aggregate of 14,753 shares of common stock to two new employees. Each option has an exercise price of $11.91, the closing price of the Co
Yahoo
CervoMed (CRVO) announced topline data from the RewinD-LB Phase 2b clinical trial evaluating neflamapimod for the treatment of patients with dementia with Lewy bodies. DLB. The trial did not meet statistical significance thresholds for its primary endpoint of change in the Clinical Dementia Rating Sum of Boxes, CDR-SB, or any of its key secondary endpoints – change from baseline in Timed Up and Go, TUG, test, change from baseline in a Neuropsychological Test Battery, NTD, and the Clinician’s Glo
Yahoo
On Tuesday, CervoMed Inc. (NASDAQ:CRVO) stock is trading lower after the company revealed topline data from the RewinD-LB Phase 2b clinical trial evaluating neflamapimod for dementia with Lewy bodies (DLB). The trial did not meet statistical significance thresholds for its primary endpoint of change in the Clinical Dementia Rating Sum of Boxes (a measure of dementia severity) or any of its key secondary endpoints – change from baseline in Timed Up and Go (measures a person’s mobility, balance, a
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CPRJ | 35.09% | $51.17M | 0.69% |
CPNJ | 24.66% | $34.66M | 0.69% |
CPSJ | 24.39% | $38.01M | 0.69% |
QQA | 24.00% | $162.24M | 0% |
FPX | 23.98% | $891.80M | 0.59% |
KOMP | 21.88% | $2.21B | 0.2% |
IPAY | 21.52% | $322.67M | 0.75% |
IPO | 21.46% | $168.38M | 0.6% |
XSW | 21.23% | $589.66M | 0.35% |
FINX | 20.78% | $333.02M | 0.68% |
ARKX | 20.60% | $315.93M | 0.75% |
IWP | 20.43% | $18.84B | 0.23% |
ARKK | 20.35% | $6.89B | 0.75% |
ARKF | 20.29% | $1.14B | 0.75% |
BUZZ | 20.03% | $57.90M | 0.75% |
WCLD | 19.95% | $513.90M | 0.45% |
SPHB | 19.84% | $327.65M | 0.25% |
IWC | 19.76% | $977.29M | 0.6% |
VBK | 19.72% | $20.62B | 0.07% |
VXF | 19.62% | $22.63B | 0.06% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
QURE | -37.07% | $866.22M | +196.34% | 0.00% |
CRDF | -25.30% | $307.32M | +156.67% | 0.00% |
UNFI | -22.07% | $1.85B | +88.75% | 0.00% |
ALK | -21.63% | $9.45B | +103.81% | 0.00% |
PUMP | -18.59% | $905.78M | +11.11% | 0.00% |
AUPH | -17.08% | $1.16B | +2.28% | 0.00% |
CL | -15.34% | $70.00B | +1.69% | 2.33% |
TSE | -15.14% | $168.87M | -19.70% | 0.83% |
QGEN | -14.69% | $9.24B | -6.48% | 0.00% |
OLLI | -14.01% | $6.61B | +42.69% | 0.00% |
REYN | -13.63% | $5.22B | -12.94% | 3.66% |
TIMB | -13.54% | $6.48B | -27.27% | 3.90% |
PTCT | -11.77% | $3.84B | +97.19% | 0.00% |
PG | -11.50% | $396.00B | +6.45% | 2.38% |
BBD | -11.30% | $11.81B | -12.62% | 1.92% |
MKC | -11.14% | $20.73B | +17.46% | 2.21% |
ZCMD | -11.10% | $36.69M | -63.58% | 0.00% |
EBR | -10.98% | $12.15B | -27.97% | 1.27% |
SBS | -10.95% | $11.55B | +9.20% | 0.00% |
VIV | -10.86% | $14.29B | -13.73% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TLTW | -<0.01% | $1.00B | 0.35% |
IAU | -0.05% | $36.25B | 0.25% |
SCHZ | -0.06% | $8.65B | 0.03% |
IBDU | -0.06% | $2.30B | 0.1% |
GLD | 0.07% | $79.74B | 0.4% |
BSV | -0.08% | $33.01B | 0.04% |
BAR | 0.08% | $930.80M | 0.1749% |
GVI | -0.08% | $3.28B | 0.2% |
GLDM | 0.08% | $10.22B | 0.1% |
LQDW | 0.10% | $212.14M | 0.34% |
IBDS | -0.11% | $2.91B | 0.1% |
DFSD | -0.12% | $4.06B | 0.16% |
FSIG | -0.13% | $1.28B | 0.55% |
NUAG | -0.14% | $37.42M | 0.21% |
DBO | 0.15% | $185.78M | 0.77% |
CGCB | 0.15% | $1.79B | 0.27% |
MBB | 0.16% | $36.71B | 0.04% |
AGGH | 0.16% | $261.74M | 0.29% |
NYF | 0.17% | $837.29M | 0.25% |
FBY | 0.19% | $182.76M | 0.99% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -18.60% | $272.15M | 1.43% |
CLOA | -17.45% | $689.39M | 0.2% |
THTA | -12.56% | $40.21M | 0.49% |
WEAT | -12.44% | $124.48M | 0.28% |
UNG | -12.39% | $717.51M | 1.06% |
TPMN | -10.68% | $33.98M | 0.65% |
EWZS | -10.33% | $117.26M | 0.6% |
DUSB | -9.52% | $1.02B | 0.15% |
FLRN | -9.03% | $2.60B | 0.15% |
UUP | -7.81% | $402.74M | 0.77% |
JBBB | -7.65% | $1.85B | 0.49% |
IBMP | -7.18% | $511.21M | 0.18% |
BCI | -7.04% | $1.31B | 0.26% |
DBA | -7.00% | $876.36M | 0.93% |
SUB | -6.76% | $8.90B | 0.07% |
ICLO | -6.75% | $301.69M | 0.2% |
SOYB | -6.61% | $28.05M | 0.22% |
JUCY | -6.39% | $309.21M | 0.6% |
IBMO | -6.35% | $509.34M | 0.18% |
BCD | -5.89% | $248.26M | 0.3% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DSP | -0.01% | $376.65M | +171.64% | 0.00% |
DORM | 0.03% | $3.95B | +58.52% | 0.00% |
GO | -0.05% | $1.68B | -31.12% | 0.00% |
NI | 0.05% | $17.83B | +52.39% | 2.82% |
ALLT | -0.05% | $355.97M | +395.19% | 0.00% |
FTS | -0.06% | $21.67B | +11.89% | 4.00% |
XBIO | -0.06% | $6.31M | +9.55% | 0.00% |
PSO | 0.06% | $11.19B | +39.22% | 1.79% |
EXR | 0.06% | $33.08B | +8.77% | 4.15% |
HALO | 0.07% | $7.37B | +64.42% | 0.00% |
CGBD | 0.08% | - | - | 8.70% |
SPSC | 0.11% | $6.77B | -1.94% | 0.00% |
HRL | 0.11% | $16.02B | -0.98% | 3.89% |
ETR | -0.11% | $35.50B | +70.00% | 5.54% |
ALDX | 0.11% | $357.30M | +85.76% | 0.00% |
SAGE | 0.12% | $445.34M | -69.39% | 0.00% |
AMC | -0.12% | $1.18B | -24.21% | 0.00% |
CNTY | 0.12% | $92.66M | -13.96% | 0.00% |
TD | 0.12% | $101.38B | -1.96% | 5.13% |
DEO | 0.13% | $62.13B | -24.29% | 3.72% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VOYA | 30.94% | $6.82B | +2.36% | 2.39% |
GRAL | 29.75% | $1.11B | +94.06% | 0.00% |
FERG | 29.37% | $36.45B | -7.77% | 1.32% |
YEXT | 27.76% | $844.85M | +10.89% | 0.00% |
FATE | 27.22% | $159.45M | -77.09% | 0.00% |
RXRX | 26.20% | $2.83B | -26.87% | 0.00% |
HPE | 25.11% | $28.10B | +37.81% | 2.42% |
MDB | 24.43% | $20.71B | -41.47% | 0.00% |
LOGC | 24.41% | $210.28M | +79.78% | 0.00% |
NNOX | 23.85% | $429.98M | +28.05% | 0.00% |
CARM | 23.73% | $20.88M | -76.19% | 0.00% |
KAI | 23.70% | $4.34B | +23.10% | 0.35% |
SIGA | 22.71% | $413.43M | +33.96% | 0.00% |
PFG | 22.65% | $18.30B | +2.88% | 3.47% |
DOCU | 22.62% | $18.96B | +83.50% | 0.00% |
HQY | 22.49% | $9.71B | +43.55% | 0.00% |
HRI | 22.20% | $5.95B | +39.21% | 1.27% |
OSCR | 22.18% | $3.65B | -11.39% | 0.00% |
ZBRA | 22.13% | $19.44B | +52.48% | 0.00% |
REX | 22.10% | $740.46M | -2.54% | 0.00% |